KGK Synergize Inc., a contract research organization (CRO) offering human clinical trials to the health nutrition industry, has entered into a non-binding letter of intent with the Center for Applied Health Sciences (CAHS).
CAHS is a U.S.-based CRO catering to the natural health products and dietary supplement industry with a special focus on human performance and sports nutrition. Pending satisfactory completion of due diligence, KGK Synergize will enter into a definitive partnership agreement with CAHS. The final announcement outlining the structure of KGK’s acquisition and details of the agreement are expected to be finalized prior to the end of the current calendar year.
“This partnership is very exciting for KGK as it allows us instant access into the U.S. Market,” stated Najla Guthrie, president and CEO of KGK Synergize Inc. “The partnership will also open up the door for us to have strong presence in the sports nutrition industry. ”
“With our recent expansion into the pharmaceutical, nutraceutical and medical food industries, this potential strategic partnership with KGK is timely as we look to accelerate the growth of CAHS,” commented Hector Lopez, principal and CMO of CAHS.